In the world of patents, the right to exclude others from using or selling an invention is granted only during the patent’s validity. Once a patent expires, this exclusivity vanishes.…
The post Understanding Patent Term Extensions: An Overview appeared…
Understanding Patent Term Extensions: An Overview Read Post »
Annual Drug Patent Expirations for PERSERIS+KIT Perseris Kit is a drug marketed by Indivior and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Indivior drug PERSERIS KIT appeared first on Drug…
Annual Drug Patent Expirations for PROAIR+HFA Proair Hfa is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from five suppliers. There are…
The post New patent expiration for Teva Branded drug PROAIR HFA appeared first…
New patent expiration for Teva Branded drug PROAIR HFA Read Post »
TYZEKA (telbivudine) Novartis Patent: 7,589,079 Expiration: Sep 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of September 10, 2023 Read Post »
Annual Drug Patent Expirations for UBRELVY Ubrelvy is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Abbvie drug UBRELVY appeared first on DrugPatentWa…
Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared f…
This chart shows the drugs with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Israel? …
Which pharmaceutical drugs have the most drug patents in Israel? Read Post »
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Taiho Oncology drug LONSURF appeared first on DrugPate…
Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are two patents protecting this drug. This drug has eleven…
The post New patent expiration for Novartis drug TYZEKA appeared first on Dru…
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Cumberland Pharms drug VIBATIV appeared …
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
Get new actionable insights and updates from BiotechBlog
